These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6867699)

  • 1. Total body potassium in patients receiving chlorthalidone and metoprolol for hypertension.
    Gray JM; Lawson DH; Boddy K; East W
    Scott Med J; 1983 Apr; 28(2):172-5. PubMed ID: 6867699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chlorthalidone alone or in fixed combination with slow-release metoprolol in the management of arterial hypertension: a long-term study of 545 patients.
    Bichisao E; Merlini L; Gambini O; Alberti D; Pollavini G
    J Int Med Res; 1989; 17(4):339-49. PubMed ID: 2676651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metoprolol with and without chlorthalidone in hypertension.
    Kubik M; Kendall M; Ebbutt A; John V
    Clin Pharmacol Ther; 1979 Jan; 25(1):25-32. PubMed ID: 363333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A controlled study on the anti-hypertensive effect of a new beta-adrenoreceptor-blocking drug, metoprolol, in combination with chlorthalidone.
    Jäättelä A; Pyörälä K
    Clin Sci Mol Med Suppl; 1976 Dec; 3():521s-523s. PubMed ID: 799561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative study of the combination of chlorthalidone with verapamil and metoprolol in arterial hypertension: evaluation by cycloergometrics].
    Candau LA; Pereira LS; Scherr C
    Arq Bras Cardiol; 1981 Aug; 37(2):133-8. PubMed ID: 6753801
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug treatment of essential hypertension. Practical guidelines.
    Dirix R; Savoye D; Tyberghein JM
    Practitioner; 1979 May; 222(1331):713-6. PubMed ID: 482222
    [No Abstract]   [Full Text] [Related]  

  • 7. A fixed combination of metoprolol slow-release and chlorthalidone, given once daily, in the long-term treatment of arterial hypertension.
    Floris B; Franchetta G; Palestini N; Sonaglioni G; Verdecchia P; Bichisao E
    J Int Med Res; 1982; 10(2):82-6. PubMed ID: 6802690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of chlorthalidone and metoprolol alone or in combination (logroton) on blood pressure, lipids, lipoproteins and circulating plasma ANF levels in essential hypertension.
    Bielmann P; Leduc G; Thibault G; Lepage J; Davignon J
    Int J Clin Pharmacol Ther Toxicol; 1991 Dec; 29(12):479-85. PubMed ID: 1839902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta blockade, diuretics, and salt restriction for the management of mild hypertension: a randomised double blind trial.
    Erwteman TM; Nagelkerke N; Lubsen J; Koster M; Dunning AJ
    Br Med J (Clin Res Ed); 1984 Aug; 289(6442):406-9. PubMed ID: 6432119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of hypertensive hyperuricemic patients with a new beta blocker-diuretic combination].
    Brandstetter G; Hoffmann H
    Wien Klin Wochenschr; 1984 Sep; 96(18):696-9. PubMed ID: 6240831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A fixed combination of metoprolol and chlorthalidone in hypertension. A clinical trial in general practice.
    Govind U; Munro BF; Robertson LI
    S Afr Med J; 1981 Dec; 60(24):921-4. PubMed ID: 7029740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ramipril decreases chlorthalidone-induced loss of magnesium and potassium in hypertensive patients.
    Simunic M; Rumboldt Z; Ljutic D; Sardelic S
    J Clin Pharmacol; 1995 Dec; 35(12):1150-5. PubMed ID: 8750365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of chlorthalidone on serum and total body potassium in hypertensive patients.
    Leemhuis MP; van Damme KJ; Struyvenberg A
    Acta Med Scand; 1976; 200(1-2):37-45. PubMed ID: 8958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antihypertensive effect of metoprolol in essential hypertension].
    Rodríguez Rodríguez FJ; Petersen Guitarte G; Paumard Fraguas A; López-Vidriero E; Franco Manera R
    Med Clin (Barc); 1983 Mar; 80(8):358-61. PubMed ID: 6855321
    [No Abstract]   [Full Text] [Related]  

  • 15. [Verapamil as a hypotensive agent. Clinical, laboratory, electro- and echocardiographic study].
    Talberg J; Fernandes EO; Chequer CV; Latreca CE; Reis NB
    Arq Bras Cardiol; 1981 Mar; 36 Suppl 1():36-40. PubMed ID: 7325861
    [No Abstract]   [Full Text] [Related]  

  • 16. Moderate sodium restriction and various diuretics in the treatment of hypertension.
    Ram CV; Garrett BN; Kaplan NM
    Arch Intern Med; 1981 Jul; 141(8):1015-9. PubMed ID: 7247587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of a metoprolol-chlorthalidone combination on arterial pressure and respiratory function].
    Dolce E; Misceo N; Pirrelli A
    Cardiologia; 1983 Jan; 28(1):5-14. PubMed ID: 6686937
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antihypertensive effectiveness and tolerance of slow-release metoprolol in fixed combination with chlorthalidone. Multicenter study on 93 patients].
    Beltrami M; Antiga F; Bola U; Caponi S; De Ranieri P; Galli G; Gasparotti G; Guidicelli N; Natali P; Panvini F
    Clin Ter; 1987 Feb; 120(4):317-21. PubMed ID: 2953532
    [No Abstract]   [Full Text] [Related]  

  • 19. The efficacy of a potassium-sparing combination of chlorthalidone and triamterene in the control of mild and moderate hypertension. I.
    Webb EL; Godfrey JC; Gertel A; Costello RJ; Applin WJ; Zisblatt M; Vukovich RA; Neiss ES
    J Int Med Res; 1984; 12(3):133-9. PubMed ID: 6376207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of a potassium-sparing combination of chlorthalidone and triamterene in the control of mild and moderate hypertension. II.
    Webb EL; Godfrey JC; Gertel A; Costello RJ; Cooper WH; Zisblatt M; Vukovich RA; Neiss ES
    J Int Med Res; 1984; 12(3):140-6. PubMed ID: 6376208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.